Other
Deferred Finance Costs Noncurrent Net
ResMed Deferred Finance Costs Noncurrent Net decreased by 22.7% to $832.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 55.6%, from $1.87M to $832.00K. Over 4 years (FY 2021 to FY 2025), Deferred Finance Costs Noncurrent Net shows a downward trend with a -11.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2018
Last reportedQ1 2026
Metric ID:
other_deferred_finance_costs_noncurrent_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.65M | $2.33M | $2.02M | $1.27M | $4.68M | $4.56M | $4.31M | $4.04M | $3.77M | $3.49M | $3.23M | $2.95M | $2.69M | $2.42M | $2.14M | $1.87M | $1.61M | $1.34M | $1.08M | $832.00K |
| QoQ Change | — | -12.0% | -13.3% | -37.4% | +269.6% | -2.4% | -5.5% | -6.4% | -6.7% | -7.4% | -7.4% | -8.6% | -9.0% | -9.9% | -11.6% | -12.5% | -14.2% | -16.7% | -19.6% | -22.7% |
| YoY Change | — | — | — | — | +76.5% | +95.7% | +113.3% | +219.1% | -19.4% | -23.6% | -25.1% | -26.9% | -28.7% | -30.6% | -33.7% | -36.5% | -40.2% | -44.7% | -49.7% | -55.6% |
Range$832.00K – $4.68M
CAGR-21.6%
Avg YoY Growth+5.6%
Median YoY Growth-27.8%
Current Streak15 quarters decline
Deferred Finance Costs Noncurrent Net at Other Companies
Frequently Asked Questions
- What is ResMed's deferred finance costs noncurrent net?
- ResMed (RMD) reported deferred finance costs noncurrent net of $832.00K in Q1 2026.
- How has ResMed's deferred finance costs noncurrent net changed year-over-year?
- ResMed's deferred finance costs noncurrent net decreased by 55.6% year-over-year, from $1.87M to $832.00K.
- What is the long-term trend for ResMed's deferred finance costs noncurrent net?
- Over 4 years (2021 to 2025), ResMed's deferred finance costs noncurrent net has grown at a -11.7% compound annual growth rate (CAGR), from $2.65M to $1.61M.